EVOKE PHARMA INC

Profile

Company Names

EVOKE PHARMA INC

Addresses

12671 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO, CA 92130

Phone Numbers

(858) 967-5454

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$6,000,001.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2010-06-16 
$6,000,001.00 
$6,000,001.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TODD 
 
BRADY 
DIRECTOR
NOVADIGM THERAPEUTICS INC   |  ASMACURE, INC.   |  EVOKE PHARMA INC   |  SEBACIA, INC.   |  ALDEXA THERAPEUTICS, INC.   |  RX GREEN SOLUTIONS LLC   |  ONCOBIOLOGICS, INC.   |  TYROGENEX, INC.   |  THERABRON THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES LLC   |  GENO LLC   |  ALDEYRA THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  VERO BIOTECH INC.   |  HYPERFRAME INC.
MATT 
 
D-ONOFRIO 
EXECUTIVE OFFICER
EVOKE PHARMA INC
CAM 
L. 
GARNER 
DIRECTOR
ZOGENIX INC   |  MERITAGE PHARMA INC   |  ELEVATION PHARMACEUTICALS INC   |  NEURELIS, INC.   |  EVOKE PHARMA INC   |  KALYRA PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  ONCTERNAL THERAPEUTICS, INC.
SCOTT 
L. 
GLENN 
DIRECTOR
EVOKE PHARMA INC   |  EXAGEN DIAGNOSTICS INC   |  SELEXAGEN THERAPEUTICS, INC.   |  KALYRA PHARMACEUTICALS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  PRECISION IBD, INC.   |  VELOSBIO INC.   |  REBALANCE HEALTH, INC.
DAVID 
A. 
GONYER 
EXECUTIVE OFFICER, DIRECTOR
EVOKE PHARMA INC   |  NEURELIS, INC.
MALCOLM 
R. 
HILL 
DIRECTOR
MERITAGE PHARMA INC   |  EVOKE PHARMA INC
KENNETH 
J. 
WIDDER 
DIRECTOR
EVOKE PHARMA INC   |  NAUREX INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#